Mantle Cell Lymphoma Management in North Carolina: Updates for 2020 SPOC

Dr. Christopher Dittus from the UNC Lineberger Lymphoma group will describe relevant updates in systemic therapy for rare lymphomas for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.

Learning Objectives

  • Explain the diagnosis of mantle cell lymphoma.
  • Describe high risk mantle cell lymphoma.
  • Describe the frontline treatment approach for mantle cell lymphoma.
  • Describe new modalities for treating relapsed mantle cell lymphoma.

Additional Information

AttachmentSize
PDF icon 2-Up PDF Handout for Mantle Cell Lymphoma Management in North Carolina: Updates for 20201.8 MB
PDF icon 3-Up PDF Handout for Mantle Cell Lymphoma Management in North Carolina: Updates for 2020983.39 KB
Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
03/24/2021
Course expires: 
12/31/2027
Photo of Christopher Dittus, DO, MPH 

Christopher Dittus, DO, MPH

Assistant Professor
Clinical Research, Hematology/Oncology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

Christopher Dittus, DO, MPH, has no relevant financial relationships with commercial interests as defined by the ACCME.

 

This Non-Credit Course does not have accreditation. It only offers general participation certificates.

Available Credit

  • 1.00 Participation
Please login or register to take this course.